ANTIBODY MOLECULES FOR CANCER TREATMENT

The present invention relates to novel anti-PD1 and anti-LAG3 antibody molecules. The invention also relates to nucleic acids encoding such antibody molecules; to methods for preparing such antibody molecules; to host cells expressing or capable of expressing such antibody molecules; to compositions...

Full description

Saved in:
Bibliographic Details
Main Authors DAVIDSON, Walter Carroll, WURM, Melanie, FORTIN, Jean-Francois, YANG, Danlin, SCHAAF, Otmar, ZETTL, Markus, GUPTA, Pankaj, LORENZ, Ivo, CHLEWICKI, Lukasz, WOSKA Jr., Joseph Robert, GUPTA, Priyanka, PEREZ, Rocio K, CANADA, Keith A, XIAO, Haiguang, BRODEUR, Scott
Format Patent
LanguageEnglish
French
German
Published 14.07.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel anti-PD1 and anti-LAG3 antibody molecules. The invention also relates to nucleic acids encoding such antibody molecules; to methods for preparing such antibody molecules; to host cells expressing or capable of expressing such antibody molecules; to compositions comprising such antibody molecules; and to uses of such antibody molecules or such compositions, in particular for therapeutic purposes in the field of cancer diseases.
Bibliography:Application Number: EP20200216343